AA
CAH icon

Armis Advisers’s Cardinal Health CAH Stock Holding History

Armis Advisers’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,252
Closed -$210K – 353
2025
Q2 		$210K Buy
+1,252
New +$186K 0.02% 445

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armis Advisers's CAH Position: Q3 2025 in Review

Armis Advisers sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 1,252 shares — an estimated $210K sold.

Armis Advisers first reported a position in CAH in Q2 2025 and held it in 1 quarter. The position peaked at $210K in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Armis Advisers reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • Armis Advisers sold 1,252 Cardinal Health shares in Q3 2025, an estimated $210K.
  • Armis Advisers first reported a position in Cardinal Health in Q2 2025 and held it in 1 quarter.
  • Armis Advisers's Cardinal Health position peaked at $210K in Q2 2025.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Armis Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.